Background illustration for clinical trials search

Paid Clinical Trials Ann Arbor

Discover 1,743 paid clinical trials in Ann Arbor, Michigan. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Amplitude-Modulated Radiofrequency Electromagnetic Fields (AM RF EMF) in Combination With Fruquintinib in Refractory Metastatic Colorectal Cancer

for
Metastatic Colorectal Adenocarcinoma
Location: Detroit MI, Clarkston MI, Macomb MI, Lansing MI,
Sponsor: Barbara Ann Karmanos Cancer Institute

Sex: All

Age: 22+

Code: NCT07130903

Phase2, Recruiting

Using Consumer-grade Wearable Devices for Fall Risk Evaluation and Alerts

for
Mass Screening
Location: Flint MI
Sponsor: University of Michigan

Sex: All

Age: 65+

Code: NCT06508892

Recruiting

A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Detroit MI, Dayton OH, Chicago IL, Rochester NY,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT06973187

Phase3, Recruiting

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

for
Ovarian Neoplasms, Breast Neoplasms,
Location: Detroit MI, Grand Rapids MI, Indianapolis IN,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07213791

Phase1, Recruiting

A First-in-Human Study of YL217 in Patients With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Detroit MI, Cleveland OH, Cincinnati OH, Durham NC,
Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.

Sex: All

Age: 18+

Code: NCT06859762

Phase1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Metformin Combined With Chemotherapy and/or Immunotherapy in Solid Malignancies

for
Advanced Solid Tumor
Location: Detroit MI, Clarkston MI, Macomb MI, Lansing MI,
Sponsor: Barbara Ann Karmanos Cancer Institute

Sex: All

Age: 18+

Code: NCT07098299

Phase1, Recruiting

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

for
Ovarian Neoplasms, Fallopian Tube Neoplasms,
Location: Detroit MI, Kalamazoo MI, Cleveland OH, Hilliard OH,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07213804

Phase3, Recruiting

Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy

for
Urothelial Cancer
Location: Detroit MI, Cleveland OH, Mayfield Heights OH,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT07106762

Phase2, Phase3, Recruiting

Increasing Knowledge and Interest in Cancer Clinical Trials

for
Hematopoietic and Lymphoid Cell Neoplasm,
Location: Detroit MI
Sponsor: Hayley Thompson

Sex: All

Age: 21+

Code: NCT06501040

Recruiting

A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)

for
Chronic Lymphocytic Leukemia (CLL),
Location: Detroit MI, Fort Wayne IN, Cleveland OH, Columbus OH,
Sponsor: Nurix Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07221500

Phase2, Recruiting

A Study to Assess the Safety and Tolerability of BMS-986525 Alone and in Combination Therapy in Participants With Relapsed/Refractory Small Cell Lung Cancer

for
Relapsed/Refractory Small Cell Lung Cancer
Location: Detroit MI, Cleveland OH, Buffalo NY, Nashville TN,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT07325136

Phase1, Phase2, Recruiting

A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma

for
Follicular Lymphoma (FL)
Location: Detroit MI, Cleveland OH, Noblesville IN,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06091254

Phase3, Recruiting

Culturally Adapting an Intervention to Increase Genetic Testing in African American Cancer Survivors

for
Female Breast Cancer, Prostate Cancer, Colorectal Carcinoma
Location: Detroit MI
Sponsor: Barbara Ann Karmanos Cancer Institute

Sex: All

Age: 20 - 70+

Code: NCT07436078

Recruiting

A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

for
Esophageal Squamous Cell Carcinoma,
Location: Detroit MI, Fairfax VA, Nashville TN, Denver CO,
Sponsor: IDEAYA Biosciences

Sex: All

Age: 18+

Code: NCT07503808

Phase1, Recruiting

A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)

for
Non-small Cell Lung Cancer (NSCLC)
Location: Detroit MI, Fort Wayne IN, Cleveland OH,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT07361497

Phase3, Recruiting

Extension Study for Participants in Studies That Include Belzutifan (MK-6482-043/LITESPARK-043)

for
Von Hippel-Lindau Disease, Malignant Neoplasms
Location: Detroit MI, Nashville TN, Philadelphia PA, Boston MA,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT07405164

Phase3, Recruiting

FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal Cancer

for
Ras-mutated Metastatic Colorectal Cancer, mCRC,
Location: Detroit MI, Canton OH, Florham Park NJ,
Sponsor: Oncolytics Biotech

Sex: All

Age: 18+

Code: NCT07446322

Phase2, Recruiting

MOnaliZumab in Combination With durvAlumab (MEDI4736) for tRreatmenT of Small Cell Lung Cancer

for
Small Cell Lung Cancer, SCLC,
Location: Detroit MI, Indianapolis IN, Iowa City IA,
Sponsor: Hirva Mamdani

Sex: All

Age: 18+

Code: NCT05903092

Phase2, Recruiting

A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma

for
Multiple Myeloma
Location: Detroit MI, Canton OH, Dayton OH, Chicago IL,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07518186

Phase3, Recruiting

A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)

for
Chronic Graft-versus-host-disease
Location: Detroit MI, Columbus OH, Chicago IL, Pittsburgh PA,
Sponsor: Syndax Pharmaceuticals

Sex: All

Age: 2+

Code: NCT04710576

Phase2, Recruiting